BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17148458)

  • 1. Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer.
    Wu C; Huang J
    J Biol Chem; 2007 Feb; 282(6):3571-83. PubMed ID: 17148458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
    Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
    Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.
    Martín-Orozco RM; Almaraz-Pro C; Rodríguez-Ubreva FJ; Cortés MA; Ropero S; Colomer R; López-Ruiz P; Colás B
    Neoplasia; 2007 Aug; 9(8):614-24. PubMed ID: 17898861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
    MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
    Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.
    Kinkade CW; Castillo-Martin M; Puzio-Kuter A; Yan J; Foster TH; Gao H; Sun Y; Ouyang X; Gerald WL; Cordon-Cardo C; Abate-Shen C
    J Clin Invest; 2008 Sep; 118(9):3051-64. PubMed ID: 18725989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.
    Kim SM; Park JH; Kim KD; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
    Phytother Res; 2014 Mar; 28(3):423-31. PubMed ID: 23686889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
    Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B
    Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y; Chen SY; Ross KN; Balk SP
    Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.
    Inoue T; Yoshida T; Shimizu Y; Kobayashi T; Yamasaki T; Toda Y; Segawa T; Kamoto T; Nakamura E; Ogawa O
    Mol Endocrinol; 2006 Dec; 20(12):3053-69. PubMed ID: 16931574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
    Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C
    BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erk/MAP kinase signaling pathway and neuroendocrine differentiation of non-small-cell lung cancer.
    Chen Y; Nowak I; Huang J; Keng PC; Sun H; Xu H; Wei G; Lee SO
    J Thorac Oncol; 2014 Jan; 9(1):50-8. PubMed ID: 24346093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function and molecular mechanisms of neuroendocrine cells in prostate cancer.
    Huang J; Wu C; di Sant'Agnese PA; Yao JL; Cheng L; Na Y
    Anal Quant Cytol Histol; 2007 Jun; 29(3):128-38. PubMed ID: 17672372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.
    Kumar R; Srinivasan S; Koduru S; Pahari P; Rohr J; Kyprianou N; Damodaran C
    Cancer Prev Res (Phila); 2009 Mar; 2(3):234-43. PubMed ID: 19223576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.
    Murillo H; Huang H; Schmidt LJ; Smith DI; Tindall DJ
    Endocrinology; 2001 Nov; 142(11):4795-805. PubMed ID: 11606446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.